| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $3.51M | $37.31M | $371.21M | $1.20M | $914.96M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $668.08M | $503.88M | $593.74M | $674.36M | $541.43M |
| R&D | $284.81M | $320.65M | $387.33M | $461.64M | $438.63M |
| SG&A | $73.54M | $72.98M | $76.16M | $102.46M | $102.80M |
| Operating Income | -$664.57M | -$466.57M | -$222.54M | -$673.16M | $373.53M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $3.63M | $3.59M | $2.89M | -$325.00K | $1.87M |
| Net Income | -$581.60M | -$366.25M | -$153.61M | -$650.17M | $377.66M |
| EPS (basic) | -6.4700 | -4.3400 | -1.9400 | -8.3600 | 4.9700 |
| EPS (diluted) | -6.4700 | -4.3400 | -1.9400 | -8.3600 | 4.7000 |
| Shares (diluted) | $89.93M | $84.36M | $79.22M | $77.75M | $80.39M |